A Perspective on the OECD Report “Health at a Glance 2019”

Fernandes, Adalberto Campos

doi:10.20344/amp.13251

Cited by 9 publications

(6 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…O aumento do valor médio dos TG no GE tem representatividade, abaixo do limite preconizado para este marcador (150 mg/dL), tal como no GC. O tabagismo foi o fator de risco menos prevalente nesta amostra com apenas um participante do GE fumador de tabaco e de outras substâncias, dados que vão ao encontro à atualidade nacional em que a média de fumadores diários com idade superior a 15 anos fica abaixo da média da OCDE (Fernandes, 2020).…”

Section: Tabelaunclassified

Impacto de um programa educativo com tecnologia online na pessoa pós-intervenção coronária percutânea

2023

View full text Add to dashboard Cite

Impacto de um programa educativo com tecnologia online na pessoa pós-intervenção coronária percutâneaThe impact of an online education program on patients who underwent percutaneous coronary intervention Impacto de un programa educativo con tecnología en línea en la persona sometida a una intervención coronaria percutânea REVISTA DE ENFERMAGEM REFERÊNCIA homepage: https://rr.esenfc.pt/rr/ ISSNe: 2182.2883 ARTIGO DE INVESTIGAÇÃO (ORIGINAL)

show abstract

Section: Tabelaunclassified

Impacto de um programa educativo com tecnologia online na pessoa pós-intervenção coronária percutânea

2023

View full text Add to dashboard Cite

show abstract

“…In the OECD (Organisation for Economic Cooperation and Development) countries, health expenditure as a percentage of GDP has increased, but the extent of this phenomenon varies between these countries [ 6 , 18 ]. In many of these countries, this growth is outpacing economic growth and it is forcing governments to spend a larger share of the budget on it.…”

Section: Introductionmentioning

confidence: 99%

Investigation the determinants of pharmaceutical expenditure share of GDP in Iran and selected OECD countries

Kadkhodamanesh

Varahrami

Zarei

et al. 2021

J of Pharm Policy and Pract

View full text Add to dashboard Cite

Aim This study estimated the GDP share of pharmaceuticals in Iran based on the drivers of pharmaceutical expenditure and compared it with that of 31 members of the Organisation for Economic Cooperation and Development (OECD). Subject and methods The factors contributing to pharmaceutical expenditure were identified through literature review and studied by 8 experts to classify the factors. Then, using the panel data method, a model was built to estimate the GDP share of pharmaceutical expenditure based on the extracted factors of the selected countries in Iran’s model. To explain the observed differences, several regression analyses were performed based on cross-sectional data. The analyses were performed using EVIEWS software, version 10. Results The explanatory variables for the selected countries in the panel model (R2 = 0.98) were specified. Government health expenditure (β = 0.1432), the share of generic drugs (β = − 0.0143), gross domestic product (GDP) per capita (β = − 0.0058) and the rate of disability-adjusted life-years (DALY) (β = 0.0028) contributed most to pharmaceutical expenditure. In comparison, in the Iranian estimation model (R2 = 0.84), government health expenditure (β = 0.0536) and the share of generic drugs (β = 0.0369) had a significant impact on pharmaceutical expenditure. In the estimation model with more estimators for Iran (R2 = 0.99), government health expenditure (β = 0.1694), disease prevalence (β = 0.0537), the share of generic drugs (β = 0.0102), the DALY rate (β = 0.0039), GDP per capita (β = − 0.0033), and the drug price index (β = 0.0007) contribute most to pharmaceutical expenditure. Conclusion In the models of the study, factors related to the structure of the healthcare system and the pharmaceutical system contributed most to pharmaceutical expenditure as a share of GDP. Moreover, disease profiles show its predictive role in the second model for Iran.

show abstract

“…Moreover, as noted in earlier reports, NPPP may have limited applicability in Japan, where a large proportion of municipalities are too small to maintain multi-specialty medical facilities [ 21 ]. In addition, although Japan had the lowest difference in the density of physicians between urban and rural communities among OECD countries in 2016 [ 26 ], a longitudinal study reported that the NPPP could not detect the shortage of physicians in rural areas [ 20 ].…”

Section: Introductionmentioning

confidence: 99%

Incorporating Medical Supply and Demand into the Index of Physician Maldistribution Improves the Sensitivity to Healthcare Outcomes

Takayama

Poudyal

2021

JCM

View full text Add to dashboard Cite

Background: Since the association between disparity in physician distribution and specific healthcare outcomes is poorly documented, we aimed to clarify the association between physician maldistribution and cerebrovascular disease (CeVD), a high-priority health outcome in Japan. Methods: In this cross-sectional study, we conducted multivariable regression analysis with the Physician Uneven Distribution Index (PUDI), a recently developed and adopted policy index in Japan that uniquely incorporates the gap between medical supply and demand, as the independent variable and CeVD death rate as the dependent variable. Population density, mean annual income, and prevalence of hypertension were used as covariates. Results: The coefficient of the PUDI for the CeVD death rate was −0.34 (95%CI: −0.49–−0.19) before adjusting for covariates and was −0.19 (95%CI: −0.30–−0.07) after adjusting. The adjusted R squared of the analysis for the PUDI was 0.71 in the final model. However, the same multivariable regression model showed that the number of physicians per 100,000 people (NPPP) was not associated with the CeVD death rates before or after adjusting for the covariates. Conclusion: Incorporating the gap between the medical supply and demand in physician maldistribution indices could improve the responsiveness of the index for assessing the disparity in healthcare outcomes.

show abstract

A Perspective on the OECD Report “Health at a Glance 2019”

Abstract: N/a.

Cited by 9 publications

References 2 publications

Impacto de um programa educativo com tecnologia online na pessoa pós-intervenção coronária percutânea

Impacto de um programa educativo com tecnologia online na pessoa pós-intervenção coronária percutânea

Investigation the determinants of pharmaceutical expenditure share of GDP in Iran and selected OECD countries

Incorporating Medical Supply and Demand into the Index of Physician Maldistribution Improves the Sensitivity to Healthcare Outcomes

Contact Info

Product

Resources

About